Based on the HCA Healthcare Inc stock forecast from 0 analysts, the average analyst target price for HCA Healthcare Inc is not available over the next 12 months. HCA Healthcare Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of HCA Healthcare Inc is Bullish , which is based on 10 positive signals and 3 negative signals. At the last closing, HCA Healthcare Inc’s stock price was EUR 290.30. HCA Healthcare Inc’s stock price has changed by -2.39% over the past week, -7.87% over the past month and +20.11% over the last year.
No recent analyst target price found for HCA Healthcare Inc
No recent average analyst rating found for HCA Healthcare Inc
Company Overview HCA Healthcare Inc
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company also operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. In addition, it operates behavioral hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, adolescent and adult alcohol, drug abuse treatment, and counseling services. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee. Read Less
HCA Healthcare, Inc., through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagno...Read More
Frequently Asked Questions About HCA Healthcare Inc (2BH:F) Stock
Stock Target Advisor's fundamental analysis for HCA Healthcare Inc's stock is Bullish .
2BH:F stock's dividend yield is 0.82%.
Our analysis grades 2BH:F stock's dividend yield at F. This means that 2BH:F stock's dividend yield is above 27% of the stocks in the Medical Care Facilities sector in the F exchange.
Based on this 2BH:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 2BH:F's stock to indicate what its average analyst target is.
2BH:F stock's Price/Earning ratio is 14.26.
Our analysis grades 2BH:F stock's Price / Earning ratio at C+. This means that 2BH:F stock's Price/Earning ratio is above 21% of the stocks in the Medical Care Facilities sector in the F exchange.
Based on this 2BH:F may be undervalued for its sector.
The last closing price of 2BH:F's stock was EUR 290.30.
The most recent market capitalization for 2BH:F is EUR 77.12B.
Unfortunately we do not have enough analyst data on 2BH:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains HCA Healthcare Inc's stock.
As per our most recent records HCA Healthcare Inc has 220,000 Employees.
HCA Healthcare Inc's registered address is One Park Plaza, Nashville, TN, United States, 37203.
You can get more information about it from HCA Healthcare Inc's website at https://www.hcahealthcare.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
Superior capital utilization
The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Underpriced compared to earnings
The stock is trading low compared to its peers on a price to earning basis and is in the top quartile. It may be underpriced but do check its financial performance to make sure there is no specific reason.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About HCA Healthcare Inc (2BH:F) Stock
Stock Target Advisor's fundamental analysis for HCA Healthcare Inc's stock is Bullish .
2BH:F stock's dividend yield is 0.82%.
Our analysis grades 2BH:F stock's dividend yield at F. This means that 2BH:F stock's dividend yield is above 27% of the stocks in the Medical Care Facilities sector in the F exchange.
Based on this 2BH:F may be a poor dividend stock for its sector.
Unfortunately we do not have enough data on 2BH:F's stock to indicate what its average analyst target is.
2BH:F stock's Price/Earning ratio is 14.26.
Our analysis grades 2BH:F stock's Price / Earning ratio at C+. This means that 2BH:F stock's Price/Earning ratio is above 21% of the stocks in the Medical Care Facilities sector in the F exchange.
Based on this 2BH:F may be undervalued for its sector.
The last closing price of 2BH:F's stock was EUR 290.30.
The most recent market capitalization for 2BH:F is EUR 77.12B.
Unfortunately we do not have enough analyst data on 2BH:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains HCA Healthcare Inc's stock.
As per our most recent records HCA Healthcare Inc has 220,000 Employees.
HCA Healthcare Inc's registered address is One Park Plaza, Nashville, TN, United States, 37203.
You can get more information about it from HCA Healthcare Inc's website at https://www.hcahealthcare.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 2BH:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
